BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

369

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2013

Conditions
Acne Vulgaris
Interventions
DRUG

BLI1100

BLI1100 topical cream

DRUG

BLI1100 - modified formulation

BLI1100 topical cream

DRUG

Placebo

Placebo topical cream

Trial Locations (15)

24501

The Education and Research Foundation, Lynchburg

30327

Peachtree Dermatology Associates Research Center, Atlanta

32174

Ameriderm Research, Ormond Beach

32204

North Florida Dermatology Associates, Jacksonville

46168

The Indiana Clinical Trials Center, Plainfield

48706

Great Lakes Research Group, Inc., Bay City

55432

Minnesota Clinical Study Center, Fridley

77056

Suzanne Bruce and Associates, Houston

77802

DiscoveResearch, Bryan

84124

Dermatology Research Center, Salt Lake City

87106

Academic Dermatology Associates, Albuquerque

94538

Center for Dermatology Clincal Research, Fremont

98105

Women's Clinical Research Center, Seattle

99204

Premier Clinical Research, Spokane

02919

Clinical Partners, Johnston

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY